Tag: percutaneous coronary intervention

1. Guided selection of antiplatelet therapy reduced rates of major adverse cardiovascular event rates compared to standard therapy. 2. Guided selection strategy was beneficial for both escalation and de-escalation of standard therapy, balancing patient-dependent ischemic and bleeding risks.  Evidence Rating Level: 1 (Excellent) Study Rundown: Patients who undergo percutaneous coronary intervention (PCI)...
1. Patients without standard modifiable cardiovascular risk factors (SMuRFs) had a significantly higher all-cause mortality at 30 days after first presentation of STEMI. 2. Patients without SMuRFs were significantly less likely to receive statins, ACEIs, ARBs, or beta-blockers at discharge.  Evidence Rating Level: 2 (Good) Study Rundown: Standard modifiable cardiovascular risk factors...
1. There was no significant difference in periprocedural myonecrosis between ticagrelor and clopidogrel among patients undergoing high-risk elective PCI. 2. Ticagrelor treatment was associated with an increased rate of minor bleeding at 30 days post-operation. Evidence Rating Level: 1 (Excellent) Study Rundown: Percutaneous coronary intervention (PCI) provides a safe therapeutic option for patients with...
1. In a modern cohort of patients with readily available primary percutaneous coronary intervention, woman experienced greater mortality rates then men following ST-elevation myocardial infarction. 2. The greater mortality was only apparent in younger patients, under the age of 60 years. Evidence Rating Level: 2 (Good) Study Rundown: Prior studies have demonstrated...
1. Amongst patients undergoing angiography, neither sodium bicarbonate nor acetylcysteine were effective in preventing a composite outcome of death, need for dialysis, or persistent kidney injury. 2. The treatments were also ineffective in reducing risk of contrast-associated acute kidney injury. Evidence Rating Level: 1 (Excellent) Study Rundown: Contrast used in angiography is...
1. On average, in this cross-sectional study, physician visual assessment overestimated coronary stenosis severity as compared to quantitative coronary angiography. 2. There was wide variation across hospitals and physicians when comparing severity of coronary stenosis. Evidence Rating Level: 3 (Average) Study Rundown: The presence and severity of coronary stenosis is determined by...
1. In patients with acute myocardial infarction (MI) with cardiogenic shock and multivessel coronary disease, culprit-lesion-only percutaneous coronary intervention (PCI) had a lower risk of 30-day mortality compared to multivessel PCI. 2. There was no evidence that rates of renal-replacement therapy, bleeding, recurrent myocardial infarction, or stroke were different between...
1. In comparison to everolimus-eluting metallic stents (EESs), bioresorbable vascular scaffolds (BVSs) increased the chances for thrombotic events at both mid- and long-term follow-up. 2. Compared to patients with EESs, those with BVSs had a heightened risk (that increased over time) of myocardial infarction, target lesion revascularization (TLR), and target...
Effect of Abdominal Ultrasound on Clinical Care, Outcomes, and Resource Use Among Children With Blunt Torso Trauma The focused assessment with sonography for trauma (FAST) exam is frequently used in the evaluation of injured adults, but little has been studied in children. In adults, the FAST exam has led to...
1. In patients with diabetes and multivessel disease, coronary artery bypass grafting (CABG) was shown to be superior to percutaneous coronary intervention (PCI) with drug-eluting stents in reducing the risk of all-cause mortality and nonfatal myocardial infarction. 2. Patients treated with PCI experienced a smaller risk of nonfatal stroke, but...